Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-23

Clinical Trial Update: BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement [NA]

View source ↗

Summary

The BOOST trial evaluating the benefit of frequent optimization after cardiac resynchronization therapy device replacement was terminated; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | NA | Status: TERMINATED | Results posted: 2013-08-23